Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Prestige Consumer Healthcare (PBH) Deferred Taxes (2016 - 2025)

Historic Deferred Taxes for Prestige Consumer Healthcare (PBH) over the last 17 years, with Q4 2025 value amounting to $3.6 million.

  • Prestige Consumer Healthcare's Deferred Taxes rose 2343.86% to $3.6 million in Q4 2025 from the same period last year, while for Dec 2025 it was $33.9 million, marking a year-over-year increase of 11958.46%. This contributed to the annual value of $14.4 million for FY2025, which is 3754.23% down from last year.
  • According to the latest figures from Q4 2025, Prestige Consumer Healthcare's Deferred Taxes is $3.6 million, which was up 2343.86% from $17.4 million recorded in Q3 2025.
  • In the past 5 years, Prestige Consumer Healthcare's Deferred Taxes ranged from a high of $17.4 million in Q3 2025 and a low of -$74.8 million during Q1 2023
  • Over the past 5 years, Prestige Consumer Healthcare's median Deferred Taxes value was $4.0 million (recorded in 2023), while the average stood at $1.2 million.
  • In the last 5 years, Prestige Consumer Healthcare's Deferred Taxes plummeted by 557851.18% in 2023 and then soared by 85212.42% in 2025.
  • Quarter analysis of 5 years shows Prestige Consumer Healthcare's Deferred Taxes stood at $3.7 million in 2021, then skyrocketed by 168.25% to $9.8 million in 2022, then tumbled by 47.29% to $5.2 million in 2023, then plummeted by 43.65% to $2.9 million in 2024, then rose by 23.44% to $3.6 million in 2025.
  • Its Deferred Taxes was $3.6 million in Q4 2025, compared to $17.4 million in Q3 2025 and $5.8 million in Q2 2025.